Jefferson Health

Physician Profile

Joanne Filicko-O'Hara, MD

Jefferson University Physician

Academic Title: Associate Professor
Program Director, Combined Fellowship in Hematology/Medical Oncology

Hematology - Medical Oncology
Medical Oncology
Medical Oncology - Bone Marrow Transplant
Medical Oncology - Hematologic Malignancies
Medical Oncology - Leukemia/Lymphoma

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

925 Chestnut Street
Suite 420A
Philadelphia PA 19107
Phone: (215) 955-8874
Fax: (215) 955-2340

Medical Services

Years in Practice


Board Certifications

  • Hematology
  • Medical Oncology

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital
  • Methodist Hospital Division of Thomas Jefferson University Hospital

Awards and Honors

Jefferson Medical College: American Medical Women's Association Faculty Award 2011

Leukemia and Lymphoma Society Service to Mankind Award 2009

Attending Teaching Award, Department of Medicine, TJUH 2008

Golden Apple Teaching Award, Department of Medicine, TJUH 2007


Also specializes in Myeloproliferative Disorders, Multiple Myeloma and Stem Cell Transplantation for Non-Malignant Diseases such as Sickle Cell Anemia and Autoimmune Diseases.


  • Hahnemann University School of Medicine, Medical School


  • Thomas Jefferson University Hospital


  • Thomas Jefferson University Hospital


  • Thomas Jefferson University Hospital

Recent Publications

Chronic lymphocytic leukemia/small lymphocytic lymphoma with pancytopenia and chylothorax

Testicular lymphoma

Antiviral Responses following L-Leucyl-L-Leucine Methyl Esther (LLME)-Treated Lymphocyte Infusions: Graft-versus-Infection without Graft-versus-Host Disease

Adenovirus DNA polymerase is recognized by human CD8+ T cells

Overlap between in vitro donor antihost and in vivo posttransplantation TCR Vβ use: A new paradigm for designer allogeneic blood and marrow transplantation

T Cell Repertoire Complexity Is Conserved after LLME Treatment of Donor Lymphocyte Infusions

Treatment of Adenovirus Disease in Stem Cell Transplant Recipients with Cidofovir

Heterogeneous clearance of antithymocyte globulin after CD34+ -selected allogeneic hematopoietic progenitor cell transplantation

Cytoprotection in acute myelogenous leukemia (AML) therapy

Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: A phase I study

Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma

Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: New approaches to prophylaxis and treatment

Sensorineural hearing loss associated with intrathecal vancomycin

Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approaches

Linezolid in the treatment of vancomycin resistant enterococcus infections in allogeneic stem cell transplant patients